BCL2 and cancer: The absolute dependence of BCL-2 overexpressing but not control cells on BCL-2 for mitochondrial cyt c retention and survival, as revealed by sensitivity to the BCL-2 antagonist ABT-737, indicates that these cells can be used to model the primed for death state that is a frequent characteristic of cancer cells.